These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29407463)

  • 1. Estimates of age-dependent cutoffs for pathological brain volume loss using SIENA/FSL-a longitudinal brain volumetry study in healthy adults.
    Opfer R; Ostwaldt AC; Sormani MP; Gocke C; Walker-Egger C; Manogaran P; De Stefano N; Schippling S
    Neurobiol Aging; 2018 May; 65():1-6. PubMed ID: 29407463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing Biological and Methodological Aspects of Brain Volume Loss in Multiple Sclerosis.
    Andorra M; Nakamura K; Lampert EJ; Pulido-Valdeolivas I; Zubizarreta I; Llufriu S; Martinez-Heras E; Sola-Valls N; Sepulveda M; Tercero-Uribe A; Blanco Y; Saiz A; Villoslada P; Martinez-Lapiscina EH
    JAMA Neurol; 2018 Oct; 75(10):1246-1255. PubMed ID: 29971335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent cut-offs for pathological deep gray matter and thalamic volume loss using Jacobian integration.
    Opfer R; Krüger J; Spies L; Hamann M; Wicki CA; Kitzler HH; Gocke C; Silva D; Schippling S
    Neuroimage Clin; 2020; 28():102478. PubMed ID: 33269702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global and regional annual brain volume loss rates in physiological aging.
    Schippling S; Ostwaldt AC; Suppa P; Spies L; Manogaran P; Gocke C; Huppertz HJ; Opfer R
    J Neurol; 2017 Mar; 264(3):520-528. PubMed ID: 28054131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Within-patient fluctuation of brain volume estimates from short-term repeated MRI measurements using SIENA/FSL.
    Opfer R; Ostwaldt AC; Walker-Egger C; Manogaran P; Sormani MP; De Stefano N; Schippling S
    J Neurol; 2018 May; 265(5):1158-1165. PubMed ID: 29549466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of High-Frequency MRI Monitoring in the Detection of Brain Atrophy in Multiple Sclerosis.
    Uher T; Krasensky J; Sobisek L; Seidl Z; Bergsland N; Dwyer MG; Kubala Havrdova E; Zivadinov R; Horakova D; Vaneckova M
    J Neuroimaging; 2018 May; 28(3):328-337. PubMed ID: 29485230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BrainLossNet: a fast, accurate and robust method to estimate brain volume loss from longitudinal MRI.
    Opfer R; Krüger J; Buddenkotte T; Spies L; Behrendt F; Schippling S; Buchert R
    Int J Comput Assist Radiol Surg; 2024 Sep; 19(9):1763-1771. PubMed ID: 38879844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis.
    De Stefano N; Stromillo ML; Giorgio A; Bartolozzi ML; Battaglini M; Baldini M; Portaccio E; Amato MP; Sormani MP
    J Neurol Neurosurg Psychiatry; 2016 Jan; 87(1):93-9. PubMed ID: 25904813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain volume dynamics in multiple sclerosis. A case-control study.
    Andravizou A; Artemiadis A; Bakirtzis C; Siokas V; Aloizou AM; Peristeri E; Kapsalaki E; Tsimourtou V; Hadjigeorgiou GM; Dardiotis E
    Neurol Res; 2019 Oct; 41(10):936-942. PubMed ID: 31280707
    [No Abstract]   [Full Text] [Related]  

  • 10. The association between brain volume loss and disability in multiple sclerosis: A systematic review.
    Matthews PM; Gupta D; Mittal D; Bai W; Scalfari A; Pollock KG; Sharma V; Hill N
    Mult Scler Relat Disord; 2023 Jun; 74():104714. PubMed ID: 37068369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
    Battaglini M; Giorgio A; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
    J Neurol Sci; 2009 Jul; 282(1-2):55-60. PubMed ID: 19286193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of Brain Volume Loss Rates in Early Stages of Multiple Sclerosis.
    Uher T; Krasensky J; Malpas C; Bergsland N; Dwyer MG; Kubala Havrdova E; Vaneckova M; Horakova D; Zivadinov R; Kalincik T
    Neurol Neuroimmunol Neuroinflamm; 2021 May; 8(3):. PubMed ID: 33727311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion of brain volume loss in a revised measure of 'no evidence of disease activity' (NEDA-4) in relapsing-remitting multiple sclerosis.
    Kappos L; De Stefano N; Freedman MS; Cree BA; Radue EW; Sprenger T; Sormani MP; Smith T; Häring DA; Piani Meier D; Tomic D
    Mult Scler; 2016 Sep; 22(10):1297-305. PubMed ID: 26585439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fingolimod on diffuse brain tissue damage in relapsing-remitting multiple sclerosis patients.
    De Stefano N; Tomic D; Radue EW; Sprenger T; Meier DP; Häring D; Sormani MP
    Mult Scler Relat Disord; 2016 May; 7():98-101. PubMed ID: 27237768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum retinol levels are associated with brain volume loss in patients with multiple sclerosis.
    Yokote H; Kamata T; Toru S; Sanjo N; Yokota T
    Mult Scler J Exp Transl Clin; 2017; 3(3):2055217317729688. PubMed ID: 28932409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra- and interscanner variability of magnetic resonance imaging based volumetry in multiple sclerosis.
    Biberacher V; Schmidt P; Keshavan A; Boucard CC; Righart R; Sämann P; Preibisch C; Fröbel D; Aly L; Hemmer B; Zimmer C; Henry RG; Mühlau M
    Neuroimage; 2016 Nov; 142():188-197. PubMed ID: 27431758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grey matter atrophy is associated with disability increase in natalizumab-treated patients.
    Ciampi E; Pareto D; Sastre-Garriga J; Vidal-Jordana A; Tur C; Río J; Tintoré M; Auger C; Rovira A; Montalban X
    Mult Scler; 2017 Apr; 23(4):556-566. PubMed ID: 27354019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teriflunomide slows BVL in relapsing MS: A reanalysis of the TEMSO MRI data set using SIENA.
    Radue EW; Sprenger T; Gaetano L; Mueller-Lenke N; Cavalier S; Thangavelu K; Panzara MA; Donaldson JE; Woodward FM; Wuerfel J; Wolinsky JS; Kappos L
    Neurol Neuroimmunol Neuroinflamm; 2017 Sep; 4(5):e390. PubMed ID: 28828394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
    Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher effect sizes for the detection of accelerated brain volume loss and disability progression in multiple sclerosis using deep-learning.
    Opfer R; Ziemssen T; Krüger J; Buddenkotte T; Spies L; Gocke C; Schwab M; Buchert R
    Comput Biol Med; 2024 Dec; 183():109289. PubMed ID: 39423705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.